Inventor · disambiguated record
Wei Kong
Also filed as: KONG WEI · KONG WEI-JIA
16 granted patents·9 pending applications·61 citations·filing 2003–2022
91Inventor score
Files withTHE ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIV7CHANGCHUN BCHT BIOTECHNOLOGY CO4CURTISS III ROY4UNIV ARIZONA STATE4JIANG JIAN-DONG2
Top patents by PatentIndex Score
25 records- 0195US8445254B2Regulated expression of antigen and/or regulated attentuation to enhance vaccine immunogenicity and/or safetyCURTISS III ROY·Filed 2009·Granted May 21, 2013·24 cites·15 claims
- 0294US9297015B2Regulated expression of antigen and/or regulated attentuation to enhance vaccine immunogenicity and/or safetyCURTISS III ROY·Filed 2013·Granted Mar 29, 2016·12 cites·16 claims
- 0391US9598697B2Recombinant bacterium to decrease tumor growthCURTISS III ROY·Filed 2011·Granted Mar 21, 2017·11 cites·18 claims
- 0490US11920139B2Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safetyTHE ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIV·Filed 2021·Granted Mar 5, 2024·1 cites·15 claims
- 0590US9885051B2Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safetyTHE ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIV·Filed 2016·Granted Feb 6, 2018·7 cites·14 claims
- 0689US10774334B2Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safetyTHE ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIV·Filed 2019·Granted Sep 15, 2020·2 cites·14 claims
- 0786US11180765B2Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safetyTHE ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIV·Filed 2020·Granted Nov 23, 2021·1 cites·16 claims
- 0882US9481888B2Recombinant bacterium and methods of antigen and nucleic acid deliveryCURTISS III ROY·Filed 2011·Granted Nov 1, 2016·3 cites·21 claims
- 0963US2023338436A1Tumor-delivered multi-target therapeutics for colon cancerUNIV ARIZONA STATE·Filed 2022·Application pending·0 cites
- 1063US2018320189A1Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safetyTHE ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIV·Filed 2017·Application pending·0 cites
- 1155US11564954B2Tumor-delivered multi-target therapeutics for colon cancerUNIV ARIZONA STATE·Filed 2020·Granted Jan 31, 2023·0 cites·3 claims
- 1254US2008081781A1Methods and compositions for the treatment of metabolic syndromeLIPPA ARNOLD S·Filed 2007·Application pending·0 cites
- 1353US12414987B2Phosphorylated polypeptide antigen vaccine, preparation method therefor and application thereofCHANGCHUN BCHT BIOTECHNOLOGY CO·Filed 2019·Granted Sep 16, 2025·0 cites·34 claims
- 1453US2011158932A1Methods And Compositions For The Treatment of HyperlipidemiaJIANG JIAN-DONG·Filed 2008·Application pending·0 cites
- 1551US11519007B2Tumor-navigating, self-eradicating, trail-armed salmonella for precision cancer therapyUNIV ARIZONA STATE·Filed 2020·Granted Dec 6, 2022·0 cites·20 claims
- 1651US2017306338A1Recombinant bacterium to decrease tumor growthTHE ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIV·Filed 2017·Application pending·0 cites
- 1749US2006140975A1Regulated bacterial lysis for gene vaccine vector delivery and antigen releaseCURTISS ROY III·Filed 2003·Application pending·0 cites
- 1848US2017224806A1Recombinant bacterium and methods of antigen and nucleic acid deliveryTHE ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIV·Filed 2016·Application pending·0 cites
- 1945US11717542B2Using tumor-navigating Salmonella to modulate tumor metabolismUNIV ARIZONA STATE·Filed 2020·Granted Aug 8, 2023·0 cites·15 claims
- 2045US9669005B2Use of naringenin in preparing drugs for preventing and/or treatment abdominal aortic aneurysmUNIV BEIJING·Filed 2014·Granted Jun 6, 2017·0 cites·6 claims
- 2145US2006223838A1Methods and compositions for the treatment of hyperlipidemiaJIANG JIAN-DONG·Filed 2005·Application pending·0 cites
- 2242US2015056247A1Sequential and repeated immunization with four or more vector-based HIV gene vaccinesZENG YI·Filed 2011·Application pending·0 cites
- 2340US10588955B2Streptococcus pneumoniae protein antigen, and preparation method and use thereofCHANGCHUN BCHT BIOTECHNOLOGY CO·Filed 2016·Granted Mar 17, 2020·0 cites·18 claims
- 2434US11116831B2Chimeric norovirus P particle and preparation and use thereofCHANGCHUN BCHT BIOTECHNOLOGY CO·Filed 2016·Granted Sep 14, 2021·0 cites·9 claims
- 2527US10463741B2Non-gelatin vaccine protectant composition and live attenuated influenza vaccineCHANGCHUN BCHT BIOTECHNOLOGY CO·Filed 2016·Granted Nov 5, 2019·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Wei Kong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →